<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02444195</url>
  </required_header>
  <id_info>
    <org_study_id>HUM00095520</org_study_id>
    <nct_id>NCT02444195</nct_id>
  </id_info>
  <brief_title>Guided Imagery in the Perioperative Period in Gynecologic Oncology Patients</brief_title>
  <official_title>Self-Administered Guided Imagery in the Perioperative Period to Reduce Postoperative Distress in Gynecologic Oncology Patients: A Randomized Control Trial</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>University of Michigan</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>University of Michigan</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The purpose of this study is to evaluate the effectiveness of self-administered perioperative
      guided imagery to reduce perioperative distress in gynecologic oncology patients undergoing
      surgical management for a presumed cancer diagnosis.
    </textblock>
  </brief_summary>
  <overall_status>Completed</overall_status>
  <start_date>April 2015</start_date>
  <completion_date type="Actual">May 1, 2016</completion_date>
  <primary_completion_date type="Actual">May 1, 2016</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Supportive Care</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Level of distress in the immediate postoperative period, measured by the numeric rating scale/ National Comprehensive Cancer Network (NCCN) Distress Thermometer screening instrument.</measure>
    <time_frame>postoperative day 1</time_frame>
  </primary_outcome>
  <primary_outcome>
    <measure>Level of distress in the delayed postoperative period, measured by the numeric rating scale/ National Comprehensive Cancer Network (NCCN) Distress Thermometer screening instrument.</measure>
    <time_frame>6-8 week postoperative exam</time_frame>
  </primary_outcome>
  <secondary_outcome>
    <measure>Level of distress, measured by questionnaire using the Hospital Anxiety and Depression Scale-total (HADS-T).</measure>
    <time_frame>postoperative day 1 and 6-8 week postoperative exam</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Level of anxiety and depressions, measured by questionnaire using the Hospital Anxiety and Depression Scale subscale for anxiety (HADS-A) and depression (HADS-D).</measure>
    <time_frame>postoperative day 1 and 6-8 week postoperative exam</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Level of pain, measured by a 7-item questionnaire using a Likert numerical rating scale for pain</measure>
    <time_frame>postoperative day 1 and 6-8 week postoperative exam</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Perioperative analgesic use, measured by patient-completed usage log and hospital medical record.</measure>
    <time_frame>postoperative day 1 and 6-8 week postoperative exam</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Patient satisfaction regarding in hospital perioperative care, measured by a questionnaire adapted from the Hospital Consumer Assessment of Healthcare Providers and Systems (HCAHPS) survey.</measure>
    <time_frame>postoperative day 1 and 6-8 week postoperative exam</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Effect of perioperative guided imagery on health care compliance, measured by the General Adherence Scale (GAS) survey.</measure>
    <time_frame>6-8 week postoperative visit</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Effect of perioperative guided imagery on health care related locus of control, measured by the Multidimensional Health Locus of Control-form A (MHLC-A) questionnaire.</measure>
    <time_frame>postoperative day 1 and 6-8 week postoperative exam</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>The effect of perioperative guided imagery on hope, measured by the Adult Hope Scale (AHS) questionnaire.</measure>
    <time_frame>postoperative day 1 and 6-8 week postoperative exam</time_frame>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">130</enrollment>
  <condition>Uterine Cervical Neoplasms</condition>
  <condition>Uterine Neoplasms</condition>
  <condition>Ovarian Neoplasms</condition>
  <condition>Urogenital Neoplasms</condition>
  <condition>Fallopian Tube Neoplasms</condition>
  <arm_group>
    <arm_group_label>Guided Imagery</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Guided Imagery With Audio Media</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Routine Postoperative Care</arm_group_label>
    <arm_group_type>No Intervention</arm_group_type>
    <description>Subjects will receive routine pre-operative, intra-operative, post-operative, chemotherapy, and radiation care as dictated by pathologic diagnosis.</description>
  </arm_group>
  <intervention>
    <intervention_type>Behavioral</intervention_type>
    <intervention_name>Guided Imagery With Audio Media</intervention_name>
    <description>Subjects assigned to the experimental arm will be asked to participate in meditation daily using the audio media provided for the 7 days prior to surgery, in the preoperative holding area, for the 7 days following surgery, and are encouraged to engage in affirmations module use at least weekly in the 6-8 week postoperative period.</description>
    <arm_group_label>Guided Imagery</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Undergoing surgical management for a suspected diagnosis of Gynecologic Malignancy
             (Endometrial, Ovarian, Vulvar, Vaginal, Primary Peritoneal, Fallopian Tube)

          -  Age 18 or greater

          -  Receiving care at University of Michigan Comprehensive Cancer Center Gynecologic
             Oncology Clinic or at St. Joseph Mercy Hospital, Alexander Cancer Care Center

          -  Able to understand and read English

          -  Eastern Cooperative Oncology Group (ECOG) performance status of 0-2

          -  Patients must have working telephone, mobile or land line

        Exclusion Criteria:

          -  Severe hearing impairment that limits the ability to use audio-based guided imagery
             modules

          -  Current documented alcohol abuse or illicit drug substance abuse

          -  Planned outpatient surgery

          -  Patients currently participating in a meditation practice for more than 1 hour per
             week prior to preoperative visit.
      </textblock>
    </criteria>
    <gender>Female</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Brandy Michaels, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>University of Michigan</affiliation>
  </overall_official>
  <overall_official>
    <last_name>J. Rebecca Liu, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>University of Michigan</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>University of Michigan Cancer Center</name>
      <address>
        <city>Ann Arbor</city>
        <state>Michigan</state>
        <zip>48109</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <verification_date>March 2017</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>May 7, 2015</study_first_submitted>
  <study_first_submitted_qc>May 11, 2015</study_first_submitted_qc>
  <study_first_posted type="Estimate">May 14, 2015</study_first_posted>
  <last_update_submitted>March 16, 2017</last_update_submitted>
  <last_update_submitted_qc>March 16, 2017</last_update_submitted_qc>
  <last_update_posted type="Actual">March 20, 2017</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>University of Michigan</investigator_affiliation>
    <investigator_full_name>Brandy Michaels</investigator_full_name>
    <investigator_title>Gynecologic Oncology Fellow</investigator_title>
  </responsible_party>
  <keyword>gynecologic cancer</keyword>
  <keyword>guided imagery</keyword>
  <keyword>postoperative distress</keyword>
  <keyword>perioperative distress</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Neoplasms</mesh_term>
    <mesh_term>Ovarian Neoplasms</mesh_term>
    <mesh_term>Uterine Cervical Neoplasms</mesh_term>
    <mesh_term>Uterine Neoplasms</mesh_term>
    <mesh_term>Urogenital Neoplasms</mesh_term>
    <mesh_term>Fallopian Tube Neoplasms</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

